Polyneuropathy Quality Measurement Set: Quality Improvement in Neurology

Brian C. Callaghan, Carmel Armon, Vera Bril, Lindsay Colbert, William S. David, David R. Del Toro, Kenneth Fink, Lyell K. Jones, Robert Kleemeier, Leslie C. MacGregor, Amy Bennett, Anant Shenoy

Research output: Contribution to journalArticlepeer-review


Peripheral neuropathy affects ∼5% of the population and diabetes is the most common cause.1 Diabetic neuropathy often leads to pain, but clinicians do not always address neuropathic pain with their patients.1,2 Given the effect of painful diabetic neuropathy (PDN) on patients' quality of life, appropriate treatment of this prevalent condition is essential.1 To increase the delivery of effective management for patients with PDN, the American Academy of Neurology Institute (AANI) published a guideline on the treatment of PDN in 2011, and recently updated this guideline.1

Original languageEnglish
Pages (from-to)22-30
Number of pages9
Issue number1
StatePublished - 4 Jan 2022


Dive into the research topics of 'Polyneuropathy Quality Measurement Set: Quality Improvement in Neurology'. Together they form a unique fingerprint.

Cite this